Fox Run Management, L.L.C. Neogenomics Inc Transaction History

Fox Run Management, L.L.C.

  • $433 Million
  • Q3 2024

A detailed history of Fox Run Management, L.L.C. transactions in Neogenomics Inc stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 26,468 shares of NEO stock, worth $453,926. This represents 0.09% of its overall portfolio holdings.

Number of Shares
26,468
Holding current value
$453,926
% of portfolio
0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$13.4 - $17.73 $354,671 - $469,277
26,468 New
26,468 $390,000
Q4 2023

Feb 13, 2024
SELL
$11.67 - $20.73 $43,412 - $77,115
-3,720 Reduced 24.38%
11,539 $186,000
Q3 2023

Nov 07, 2023
SELL
$12.15 - $17.85 $283,252 - $416,137
-23,313 Reduced 60.44%
15,259 $187,000
Q2 2023

Aug 11, 2023
SELL
$14.1 - $19.83 $130,269 - $183,209
-9,239 Reduced 19.32%
38,572 $619,000
Q1 2023

May 12, 2023
BUY
$9.09 - $19.45 $274,790 - $587,973
30,230 Added 171.95%
47,811 $832,000
Q4 2022

Feb 07, 2023
BUY
$6.45 - $12.07 $113,397 - $212,202
17,581 New
17,581 $162,000
Q2 2022

Aug 12, 2022
SELL
$7.06 - $13.97 $108,872 - $215,431
-15,421 Closed
0 $0
Q1 2022

May 10, 2022
BUY
$12.15 - $35.28 $187,365 - $544,052
15,421 New
15,421 $187,000
Q4 2021

Feb 09, 2022
SELL
$30.49 - $48.49 $320,145 - $509,145
-10,500 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$41.66 - $52.52 $437,429 - $551,460
10,500 New
10,500 $507,000
Q4 2019

Feb 14, 2020
SELL
$18.96 - $29.84 $222,343 - $349,933
-11,727 Closed
0 $0
Q3 2019

Oct 15, 2019
BUY
$19.12 - $26.24 $224,220 - $307,716
11,727 New
11,727 $224,000
Q1 2019

Oct 17, 2019
SELL
$12.14 - $20.46 $185,256 - $312,219
-15,260 Closed
0 $0
Q4 2018

Jan 15, 2019
BUY
$11.24 - $18.5 $171,522 - $282,310
15,260 New
15,260 $192,000

Others Institutions Holding NEO

# of Institutions
294
Shares Held
124M
Call Options Held
698K
Put Options Held
120K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.16B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email